Evaluate the Impact of Drawtex in Venous Leg Ulcers
Clinical Study to Comparatively Evaluate the Impact of Drawtex Wound Dressing Against Wound Bioburden in Moderately to Highly Exuding Venous Leg Ulcers
Sponsor: Beier Drawtex Healthcare, (PTY). Ltd
Listed as NCT01319123, this NA trial focuses on Moderatley to Highly Exuding Venous Leg Ulcers and remains completed. Sponsored by Beier Drawtex Healthcare, (PTY). Ltd, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beier Drawtex Healthcare, (PTY). Ltd
- Southwest Regional Wound Care Center
For direct contact, visit the study record on ClinicalTrials.gov .